Bioequivalence study confirms that our artemether with lumefantrine combination is BIOEQUIVALENT to Coartem.

Malmed and Fantem range launched in Ghana

Malmed and Fantem range launched in Malawi.

Have launch OTC products under Ocean Health & Medical Pvt Ltd in a joint venture with foreign partners.

Completed stability studies for 14 days after reconstitution of FANTEM Suspension ( Artemether 180 with Lumefantrine 1080 ).

Registration of various our antimalarial products is in final stages of approval in FRANCOPHONE COUNTRIES.

Kenya Fantem tablets and Suspension is scheduled to be launched in the month of March 2009.

Fantem range launched in Zambia.